13F
← All fund report cards

Gerber Kawasaki Wealth & Investment Management

13F equity value
$3.1B
Positions
350
Top 10 concentration
42.6%
Quarters / total new picks
32 / 779
13F equity value over time
$0M$2B$3B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +3.4% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 53.1% of quarters (excess t = 0.26, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+0.6%
t-stat
0.26
Quarterly win rate
53%
Annualized excess
+2.0%
$1 → follow vs universe
$2.42 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 0.98320180630: follow 0.97520180930: follow 1.02520181231: follow 1.20820190331: follow 1.21820190630: follow 1.22420190930: follow 1.38020191231: follow 1.29020200331: follow 1.44420200630: follow 1.62920200930: follow 1.92520201231: follow 1.80820210331: follow 2.05120210630: follow 2.38220210930: follow 2.14220211231: follow 1.49720220331: follow 1.83120220630: follow 1.56620220930: follow 1.55120221231: follow 1.53120230331: follow 1.49020230630: follow 1.40120230930: follow 1.57620231231: follow 1.64920240331: follow 1.67320240630: follow 1.65720240930: follow 1.69820241231: follow 1.92820250331: follow 1.94820250630: follow 2.05020250930: follow 2.04920251231: follow 2.418 0.84 1.72 2.61 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 350 · 2026 Q1

Ticker Value Weight QoQ
QQQM $239M
7.6%
ADD
SPYG $169M
5.4%
ADD
NVDA $147M
4.7%
TRIM
SPYV $144M
4.6%
ADD
IXUS $137M
4.3%
ADD
AGG $124M
3.9%
ADD
TSLA $105M
3.4%
ADD
AAPL $103M
3.3%
HOLD
XLK $92M
2.9%
ADD
GOOG $78M
2.5%
HOLD
XLF $73M
2.3%
ADD
XLY $63M
2.0%
ADD
XLV $57M
1.8%
HOLD
LGLV $55M
1.8%
TRIM
MSFT $53M
1.7%
ADD
SCHD $53M
1.7%
TRIM
PWZ $46M
1.5%
ADD
SPBO $44M
1.4%
ADD
SOXX $44M
1.4%
TRIM
USHY $43M
1.4%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.